Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
FORWARD LOOK
Gregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
Study supports use of single-session, higher-dose radiation.
by Jane Langille
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
Severe hearing loss may result in reading and learning difficulties.
by Esther Landhuis
Survivor Profile
School counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her cancer diagnosis led her into patient advocacy.
by Marci A. Landsmann
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
In a randomized study, weight loss and home-based exercise did not improve lymphedema symptoms in breast cancer survivors.
by Anna Azvolinsky
After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
The fall 2019 Cancer Today tells the stories of advocates who are using the internet to amplify their voices, patients who are navigating the world of complementary medicine and researchers who are devising new immunotherapies.
by Kevin McLaughlin
Despite progress in developing new treatment modalities for patients with breast cancer, there is still substantial work to be done in the field.
The immune checkpoint inhibitor Keytruda (pembrolizumab) has been approved for use by some patients with endometrial cancer.
October is Liver Cancer Awareness Month. Here’s a look at the latest statistics and trends.
Follow My Lead
donate to the AACR